Skip to main content
Figure 6 | Molecular Pain

Figure 6

From: A role of periaqueductal grey NR2B-containing NMDA receptor in mediating persistent inflammatory pain

Figure 6

Changes in the PWL by Hyperoside. (A) PWL in the CFA-treated paws (ipsilateral) from the control, Hyp, CFA + saline, and CFA + Hyp treated mice. (B) PWL in the right hind paws (contralateral) from the control, Hyp, CFA + saline, and CFA + Hyp treated mice. Values (in A and B) were significantly different from saline control * p < 0.05, ** p < 0.01; from CFA-injected alone, # p < 0.05. (C) Paw volume in the CFA-treated and contralateral paws from control and Hyp treated mice. Values (in C) were significantly different from contralateral paws ** p < 0.01.

Back to article page